Navigation Links
Global Pharm Holdings Group Announces Fiscal Year 2010 Financial Results
Date:4/14/2011

,665229,587Total assets$43,177,453$28,840,912LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Short term loans$

1,972,150$

219,751Bank acceptance21,212219,751Accounts payable20,013,15713,598,744Accrued salary568,887218,546Income taxes payable1,177,439944,143Other taxes payable551,060552,560Other accrued liabilities362,879161,825Due to related party882,5052,665,768Total current liabilities25,549,28918,581,088Stockholders' equity:Common stock, par value, $ 0.001 per share, 100,000,000 shares authorized, 26,000,000 and 19,094,000 issued and outstanding in 2010 and 2009, respectively.26,00019,094Additional paid-in capital9,200,6232,489,129Statutory surplus reserves1,310,7011,310,701Retained earnings6,546,4066,206,903Accumulated other comprehensive income544,434233,997Total stockholders' equity17,628,16410,259,824Total liabilities and stockholders' equity$43,177,453$28,840,912GLOBAL PHARM HOLDINGS GROUP, INC.CONSOLIDATED STATEMENTS OF CASH FLOWSFOR YEARS ENDED DECEMBER 31, 2010 AND 200920102009Cash flows from operating activitiesNet Income$

11,152,142$

10,901,402Adjustments to reconcile net income to net cash provided by operating activities:Depreciation and amortization68,16850,392Loss on disposal of property, plant and equipment4,711-Stock-based compensation5,968,400-Merger cost750,000-Changes in operating assets and liabilities:Accounts receivable(7,447,036)(3,145,877)Other receivables(164,805)(22,781)Prepaid expenses(1,127,002)-Inventories(6,185,205)(2,195,407)Accounts payable5,775,6312,526,380Accrued payroll333,57970,527Other accrued liabilities190,175138,725Income taxes payable194,516236,928Other taxes payable(20,569)139,620Due to related party908,0571,463,979Restricted cash(1,497,838)-Net cash provided by operating activities8,902,92410,163,888Cash flows from investing activitiesPurchases of property, plant and equipment(107,952)(155,971)Proceeds on sale of property, plant, and equipment61,436-Net cash used in inves
'/>"/>

SOURCE Global Pharm Holdings Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. The American Chamber of Commerce in Spain Awards the Global Business Leader Award 2011 to Victor Grifols Roura, President and CEO of Grifols
2. Tibotec Advances Global Clinical Research Program for TMC435 in HCV; Will Present Four Abstracts Evaluating Safety and Efficacy at EASL
3. Reportlinker Adds Quantum Dots: Technologies and Global Markets
4. Reportlinker Adds Global Angiongenesis Inhibitors and Stimulators Industry
5. Reportlinker Adds Global Nanobiotechnology Industry
6. Reportlinker Adds Global Biochips Industry
7. Top 5 Global Pharmaceutical Company Selects NewCardios QTinno for 2 Upcoming Phase I Drug Safety Trials
8. Global Growth Factors ( Blood And Tissue ) Industry
9. Global HPLC Systems & Accessories Industry
10. Global Specialty Enzymes Industry
11. BioNeutral Enters into Global Sales and Distribution Agreement with Raymond Associates to Expand Market for Military-Grade Ygiene(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... RESEARCH TRIANGLE PARK, N.C. , July 14, ... company focused on cloud-based drug design and development, ... and development program. The company has been granted ... inhibitors of multiple parasitic targets.  ... at the Argonne Leadership Computing Facility (ALCF), researchers ...
(Date:7/14/2014)... Throughout this past June 100s of ... space, representing 38 countries globally, registered for Xtalks ... Participation in Clinical Trials. Attract. Engage. Retain.” , ... R&D expert, Ken Getz, of Tufts CSDD, who ... through Patient Centricity. , Throughout this complimentary six-part ...
(Date:7/14/2014)... 2014 Minerva Neurosciences (NASDAQ: NERV ... to treat neuropsychiatric diseases and disorders, today announced that ... president of finance and chief accounting officer, effective June ... executive with more than 20 years of experience in ... companies. His background includes the management of compliance and ...
(Date:7/14/2014)... (PRWEB) July 14, 2014 ... registry platform, announced that three PatientCrossroads-based patient ... the Phelan-McDermid Syndrome International Registry; and the ... been awarded contracts by the Patient-Centered Outcomes ... creation of a new health data network ...
Breaking Biology Technology:Cloud Pharmaceuticals Granted 1M Hours of Supercomputer Time to Target Orphan Diseases Including Malaria 2Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 2Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 3Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 4Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 5Minerva Neurosciences Announces Appointment Of Frederick W. Ahlholm As VP Of Finance And Chief Accounting Officer 2PatientCrossroads Fuels Development of New National Clinical Research Network 2PatientCrossroads Fuels Development of New National Clinical Research Network 3
... Suzanne DeCann visits the University of Wisconsin-Eau Claire ... to pick up her newly earned Master of Business Administration ... the first 11 UW-Eau Claire students to earn their MBAs ... shell get her first real look at the campus and ...
... South Carolina , a health insurance provider that ... its evolving document communication needs by designating two ... Esker DeliveryWare Platform and Esker Fax respectively provide ... fax. , ,BlueCross BlueShield has enlisted Esker software ...
... Middleton-based provider of testing instruments used in support of ... announced the purchase of Masthead Imagings assets. ... are the PIPSpro software package and QC-3 phantom, for ... PIPSpro software displays, enhances and analyzes portal images and ...
Cached Biology Technology:UW-Eau Claire graduates first online MBAs 2UW-Eau Claire graduates first online MBAs 3Blue Cross BlueShield of South Carolina implements Esker solutions 2Standard Imaging acquires Canadian PIPSpro radiation treatment technologies 2
(Date:7/14/2014)... How does oxygen control insect body size? What influence does ... first issue of Current Opinion in Insect Science ... questions. , Current Opinion in Insect Science is ... is a review journal that aims to provide specialists with ... of information published in the field of insect science. First ...
(Date:7/14/2014)... Biogerontology Research Foundation (BGRF), a UK-based charity founded ... of a rapidly ageing population, hosted the inaugural ... with Aging Analytics, a company supporting financial decision-making ... The speakers at the forum included: , Dmitry ... on ,Impact Investment to Advance Longevity Research, , ...
(Date:7/14/2014)... Kansas scientists to the discovery and description of Rhipidocyrtus ... specimen, which turned out to represent a new genus and ... wedge beetle from Borneo is discussed in a recent paper ... . , The holotype male, and only known specimen of ... Borneo but subsequent to this it was transferred among several ...
Breaking Biology News(10 mins):BGRF hosts inaugural 21st Century Medicine Forum 2Serendipity at the Smithsonian: The 107-year journey of the beetle Rhipidocyrtus muiri 2Serendipity at the Smithsonian: The 107-year journey of the beetle Rhipidocyrtus muiri 3
... N.C. Feb. 28, 2013 Researchers at Wake ... special population of adult stem cells in bone marrow ... intestine and produce intestinal cells, suggesting their potential to ... (IBD). Up to 1 million Americans have IBD, ...
... -- In a new study, biologists will investigate the ... has killed a record number of frogs, toads and ... received a $595,000 grant from the National Science Foundation ... and a fungus called Batrachochytrium dendrobatidis (Bd). ...
... decimate the normal intestinal microbiota, which may never ... the GI tract vulnerable to being colonized by ... New York, NY, and Centro Superior de Investigacin ... normal microbial diversity largely eliminated vancomycin-resistant enterococci (VRE) ...
Cached Biology News:Research supports promise of cell therapy for bowel disease 2Biologists explore link between amphibian behavior and deadly disease 2Biologists explore link between amphibian behavior and deadly disease 3Good bacteria may expunge vancomycin-resistant bacteria from your gut 2
... of Taq DNA polymerase. It is a ... Expressed from a gene construct in E. ... 5'-3' exonuclease domain of the DNA polymerase-encoding ... and even more heat-stable DNA polymerase activity ...
... (ELISA) test kits are qualitative one-step kits ... of drugs and/or their metabolites in forensic ... use only. It is recommended that all ... method such as GC/MS. The simple ...
... inhibitor that noncovalently binds and inactivates neutral pancreatic ... RNase 1, T1, T2, H, U1, U2 or ... inhibitor in that it has a more robust ... RNase in the absence of DTT or other ...
...
Biology Products: